Author(s):
camleshR. Sunitha, S. Madhavi Latha, M. Pavani, K. Anjali, D. Durga Siva Prasad, M. Lakshmi Mounika, Hanumayamma, Ch. Kalavathi, Gurappa, SK. Inthiyaz
Email(s):
raminenisunitha@gmail.com
DOI:
10.52711/2231-5713.2025.00018 
Address:
camleshR. Sunitha1*, S. Madhavi Latha2, M. Pavani1, K. Anjali1, D. Durga Siva Prasad1, M. Lakshmi Mounika1, Hanumayamma1, Ch. Kalavathi1, Gurappa1, SK. Inthiyaz1
1A M Reddy Memorial College of Pharmacy, Petlurivaripalem, Narasaraopet, A.P., India.
2Aditya College of Pharmacy, Surampalem, East Godavari (DT), A.P., India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
The current study paying attention on the Investigation of hydrodynamically balanced regioselective restricted release DDS for a BCS class II drug using various polymers. At first, an analytical technique was established for the pharmaceutical compound, then the absorption maxima were identified, and a Standard plot was constructed with varying concentrations. The gas-generating agent, NAHCO3 was fine-tuned for optimal concentration. Subsequently, the formulation was created using varying amounts of polymers such as Hibiscus mucilage, Okra, Lannea Coromandelica gum, and Polyox WSR 303. Preformulation investigations and evaluations of flow characteristics revealed that all formulations exhibited favorable flow properties. The formulations underwent several pharmacopoeial tests, are uniformity of weight, thickness, hardness, friability. The vitro buoyancy, drug release patterns of the formulations were assessed through kinetic modeling. After conducting in vitro buoyancy and in vitro release experiments, it was determined that the combination of Lannea Coromandelica and Polyox WSR 303 exhibited the most favorable kinetics. The research indicated that utilizing a blend of natural and synthetic polymers is more advantageous for creating GRDDS. Natural polymers can maintain drug release over a specific timeframe before triggering a sudden release, whereas the combination of natural and synthetic polymers allows for controlled release at reduced concentrations. The most effective formulation, F12, was chosen for release kinetic investigations, demonstrating that F12 adhered to a non-fickian release mechanism as indicated by the graphs acquired.
Cite this article:
camleshR. Sunitha, S. Madhavi Latha, M. Pavani, K. Anjali, D. Durga Siva Prasad, M. Lakshmi Mounika, Hanumayamma, Ch. Kalavathi, Gurappa, SK. Inthiyaz. Design and Optimization of Hydrodynamically Balanced Regioselective Controlled Release Drug Delivery of Bcs Class Ii Drug by using Natural and Synthetic Polymers. Asian Journal of Pharmacy and Technology. 2025; 15(2):107-5. doi: 10.52711/2231-5713.2025.00018
Cite(Electronic):
camleshR. Sunitha, S. Madhavi Latha, M. Pavani, K. Anjali, D. Durga Siva Prasad, M. Lakshmi Mounika, Hanumayamma, Ch. Kalavathi, Gurappa, SK. Inthiyaz. Design and Optimization of Hydrodynamically Balanced Regioselective Controlled Release Drug Delivery of Bcs Class Ii Drug by using Natural and Synthetic Polymers. Asian Journal of Pharmacy and Technology. 2025; 15(2):107-5. doi: 10.52711/2231-5713.2025.00018 Available on: https://ajptonline.com/AbstractView.aspx?PID=2025-15-2-2
REFERENCES:
1. Raghavendra Kumar Gunda, Vijayalakshmi A. Formulation Development and Evaluation of Gastro Retentive Drug Delivery Systems- A Review. Journal of Pharmacy Research. 2017; 11(2): 167-78.
2. Gunda RK, Vijayalakshmi A. Formulation Development and Evaluation of Gastro Retentive Bio Adhesive Drug Delivery System for Moxifloxacin. HCl. Indian Journal of Pharmaceutical Education and Reserach. 2019; 53(4): 724-32.
3. Raghavendra Kumar Gunda, A. Vijayalakshmi. Statistical design, formulation and evaluation of gastroretentive floating tablets for Moxifloxacin using natural and semisynthetic polymers. Thai J Pharm Sci. 2019; 43(3): 138-145.
4. Loh ZH, Samanta AK, Heng PW. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian Journal of Pharmaceutical Sciences. 2015; 10: 255-74. https://doi.org/10.1016/j.ajps.2014.12.006.
5. Noor Mohammed Dawood et al. Formulation and characterization of lafutidine nanosuspension for oral drug delivery system. International Journal of Applied Pharmaceutics. 2018, 10(2), 20-30. DOI: http://dx.doi.org/10.22159/ijap.2018v10i2.23075
6. Leon Lachman, Herbert a. Liberman, The Theory and Practice of Industrial Pharmacy: p. 293-302.
7. Gennaro R. A. Remington, the Science and Practice of Pharmacy, 20th ed. New York: Lippincott Williams: (2000) p. 1045.
8. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: A review. AAPS Pharm Sci Tech. 2005; 6: E372-90.
9. N. M. Vageesh et al., Formulation development and in vitro evaluation of floating tablets of lafutidine by employing effervescent technology, Asian J. Pharm. Res. 2017; 7(3): 189-197. doi: 10.5958/2231-5691.2017.00029.6
10. Kharwade RS et al. Formulation and evaluation of gastroretentive floating tablet using Hibiscus Rosa Sinensis Mucilage. Assian Journal of Pharmaceutical And Clinical Research. 2017; 10(3). DOI: https://doi.org/10.22159/ajpcr.2017.v10i3.16494.
11. Ikoni J. Ogaji et al. Novel extraction and application of okra gum as a film coating agent using theophylline as a model drug. J Adv Pharm Tchnol Res. 2014; 5(2): 70-77. doi: 10.4103/2231-4040.133427
12. D. Lohithasu et al. Isolation and Evaluation of binding property of lanneacoromandelica gum. Indian Journal of Pharmaceutical Sciences. 2016; 78(2): 224-230. DOI:10.4172/pharmaceutical-sciences.1000107
13. Ch. Sneha et al. Formulation and evaluation of lafutidine floating tablet. Pharmacreations. 2020; 7(2). DOI: 10.20959/wjpr201713-9832
14. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: A review. AAPS Pharm SciTech. 2005; 6: E372-90. doi: 10.1208/pt060347
15. Yamagishi H, Koike T, Ohara S, Horii T, Kikuchi R, Kobayashi S, et al. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole. World J Gastroenterol. 2008; 14: 2406- 10. doi: 10.3748/wjg.14.2406
16. Patil SH, Talele GS. Formulation development and in vitro and in vivo evaluation of gastro retentive floating drug delivery system of Lafutidine. Asian J Pharm. 2013; 7: 68-74. DOI:10.4103/0973-8398.115969
17. Dave, B.S., Amin, A.F., Patel, M.M. Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS PharmSciTech. 2004 Apr 8; 5(2): e34. doi: 10.1208/pt050234.
18. Desai S, Bolton S. A floating controlled release system: in-vitro and in-vivo evaluation. J. Pharm. Res. 1993: 10: 1321-1325. DOI: 10.1023/a:1018921830385
19. N. M. Vageesh et al. Formulation development and in vitro evaluation of floating tablets of lafutidine by employing effervescent technology, Asian J. Pharm. Res. 2017; 7(3): 189-197. doi: 10.5958/2231-5691.2017.00029.6
20. Jose, Khalid Shah. Gastroretentive drug delivery system, business brief, Pharmtech. 2003: 165-173.
21. Garima Chawla. A means to address regional variability in intestinal drug absorption. Pharmtech. 2003: 234-238
22. B. N. Singh, H. Kim. Floating drug delivery system an approach to control drug delivery via gastric retention. J. Controlled Release. 2000: 63(7); 235-259.
23. Ramdas T. Dolas et al. Formulation and evaluation of gastroretentive floating tablets of lafutidine, Journal of Drug Delivery and Therapeutics. 2018; 8(5): 393-399.
24. Nayak AK, Maji R, Das B. Gastroretentive drug delivery system: a review. Asian J Pharm Clin Res. 2010; 3:2-10.
25. Ikawa K, Shimatani T, Hayato S, Morikawa N, Tazuma S. Pharmacokinetics and Pharmacodynamics Properties of Lafutidine after Postprandial Oral Administration in Healthy Subjects: Comparison with Famotidine Biol. Pharm. Bull. 2007; 30(5): 1003-1006.
26. Patrick J. Sinko. Micrometrics. In: Martin’s Physical Pharmacy and Pharmaceutical Sciences.5th ed., Lippincott Williams and Wilkins –Indian Edition.2006: pp.553 –559.
27. Glibert S. Banker and Neil R. Anderson. Tablets. In: The theory and Pratice of Industrial Pharmacy. 3rd ed., Varghese Publishing House. 1987; 293-345
28. United States Pharmacopoeial Convention, United States Pharmacopoeia and National Formulary, Asian ed., United States Pharmacopoeial Convention, Inc., Rockville, MD, 2007; 1: 819-820.
29. Rohith G, Sridhar BK, Srinatha A. Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation. Acta Pharm. 2009 Sep; 59(3): 345-54. doi: 10.2478/v10007-009-0021-z.
30. Roy P, Shahiwala A. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough. Eur J Pharm Sci. 2009 Jun 28; 37(3-4): 363-9. doi: 10.1016/j.ejps.2009.03.006.